Related Experiment Video
Updated: Jan 8, 2026
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Defining the critical roles of factor VIII residues 1900 to 1908 in factor VIIIa-factor IXa complex formation and
Haixia Lv1, Zhe Ming2, Dongmei Wang2
1College of Life Science, State Key Laboratory Cell Differentiation and Regulation and Henan International Joint Laboratory for Pulmonary Fibrosis, Henan Normal University, Xinxiang, Henan, China; Pharmacy College, Xinxiang Medical University, Xinxiang, Henan, China.
Background:
Factor (F)VIIIa acts as a cofactor with FIXa on phospholipid surfaces to convert FX to FXa. Region 1900 to 1908 is a known FVIIIa antibody epitope, with mutations in this region linked to hemophilia A. However, its role in FXase activity is unclear. This study investigates how individual residues within 1900 and 1908 affect interprotein affinity and cofactor activity.
Objectives:
This study investigated how individual residues within region 1900 to 1908 contribute to interprotein affinity and cofactor activity.
Methods:
The mutations were generated by site-directed mutagenesis. Recombinant FVIII light chain (LC) wild type (WT) and variants were expressed in Bac-to-Bac Baculovirus Expression System and then purified. The activity, stability, and affinity of LC variants were assessed by FXa generation assay and fluorescence anisotropy. The structures of FVIIIa were predicted using PSIPRED (v3.3) and Phyre2.
Results:
FXa generation assays revealed that D1903A/E1904A/K1906A/S1907A variants showed 8.4- to 20.3-fold and 3.9- to 5.6-fold increases in apparent dissociation constant for FXase and FVIIIa reconstitution, respectively, compared with WT. Reduced fluorescence anisotropy was observed when fluorescein-Phe-Phe-Arg-FIXa bound to FVIIIa reconstituted with D1903A, E1904A, K1906A, and S1907A variants compared with WT. In both the presence and absence of FIXa, D1903A and E1904A exhibited faster decay rates than WT. While WT FVIIIa showed a 3.26-fold slower decay rate and 0.64-fold shorter half-life in the absence of FIXa compared with its presence, the decay rates and half-lives of FVIIIa reconstituted with D1903A and E1904A remained similar regardless of FIXa presence, suggesting that these mutations abrogate the normal FIXa-mediated stabilization of FVIIIa.
Conclusion:
Our study identifies FVIIIa residues 1900 to 1908 as key determinants of FIXa binding, advancing understanding of FXase assembly and A3-domain-mediated regulation of complex stability and activity.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:11Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:16Clot Retraction and Fibrinolysis
01:29Venous Thrombosis III: Interprofessional Care